Premium
Treatment of erlotinib‐induced acneiform eruption with chromophore gel‐assisted phototherapy
Author(s) -
Mahendran Akalya,
Wong Xin L.,
Kao Steven,
Sebaratnam Deshan F.
Publication year - 2019
Publication title -
photodermatology, photoimmunology and photomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.736
H-Index - 60
eISSN - 1600-0781
pISSN - 0905-4383
DOI - 10.1111/phpp.12446
Subject(s) - medicine , erlotinib , dermatology , erythema , acne , minocycline , benzoyl peroxide , rash , cancer , epidermal growth factor receptor , chemistry , polymer , organic chemistry , microbiology and biotechnology , polymerization , biology , antibiotics
A 49-year-old female presented with an acneiform eruption induced by erlotinib. She had been diagnosed with Stage IV (T1N3M1) EGFR mutant adenocarcinoma of the lung and commenced on erlotinib 150mg daily. Within three days she developed an acneiform eruption prompting empiric treatment with topical hydrocortisone and systemic doxycycline 100mg daily. The acneiform eruption progressed with evolution to widespread pustules and papules with proud erythema involving the entire face with minor extension to the scalp, décolletage and back (Fig. 1). This article is protected by copyright. All rights reserved.